Monoclonal Antibody to Tumor Necrosis Factor α Attenuates Cardiopulmonary Dysfunction in Porcine Gram-negative Sepsis

Ciaran J. Walsh, FRCSI; Harvey J. Sugerman, MD; Patrick G. Mullen, FRCSI; P. Declan Carey, FRCSI; Sandra K. Leeper-Woodford, PhD; Gary J. Jesmok, PhD; Earl F. Ellis, PhD; Alpha A. Fowler, MD
Arch Surg. 1992;127(2):138-145. doi:10.1001/archsurg.1992.01420020020003.
Text Size: A A A
Published online

• Tumor necrosis factor (TNF) is implicated in the pathophysiology of gram-negative sepsis. This study examined physiologic and biochemical effects of pretreatment with an anti-TNFα monoclonal antibody immediately before the onset of sepsis. Three groups of anesthetized ventilated pigs were studied for 300 minutes. Groups 1 (n=12) and 2 (n=6) received a 1-hour infusion of live Pseudomonas aeruginosa. Group 2 was pretreated with anti-TNFα monoclonal antibody (15 mg/kg). Group 3 (n=8) received intravenous sterile saline. Group 1 exhibited a significant rise in plasma TNF activity, which was abolished in group 2. Cardiac index was reduced in both groups 1 and 2 in the first hour but recovered in group 2 (3.3±0.4 L/min per square meter at 300 minutes in group 2 vs 1.3±0.2 L/min per square meter in group 1). Metabolic acidosis was attenuated (arterial pH, 7.39±0.01 in group 2 vs 7.16±0.03 at 300 minutes in group 1). Increased extravascular lung water was also attenuated (5.9±0.7 in group 2 vs 13.2±1.5 mL/kg at 300 minutes in group 1). However, pulmonary hypertension and hypoxemia, which are known cyclooxygenase effects, were not affected. In the early phase of the study, plasma thromboxane B2 levels were elevated in both groups 1 and 2. We conclude that anti-TNFα monoclonal antibody offered significant protection against the effects of sepsis, but that other mediators may be responsible for the early changes seen in this model.

(Arch Surg. 1992;127:138-145)


Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.